Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 6.83M $216.31M Dec. 31, 2014
BlackRock Fund Advisors 5.02M $158.96M Dec. 31, 2014
Vanguard 4.59M $145.29M Dec. 31, 2014
Visium Asset Management 3.40M $52.50M March 31, 2013
Inves 3.31M $104.73M Dec. 31, 2014
Wells Fargo & Company 2.71M $55.10M June 30, 2012
Franklin Resources 2.51M $79.61M Dec. 31, 2014
STATE STREET CORPORATION 2.45M $77.61M Dec. 31, 2014
FMR 2.30M $54.47M Sept. 30, 2014
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
BlackRock Institutional Trust Company, N.A. 1.81M $57.19M Dec. 31, 2014
TCW 1.66M $42.96M Sept. 30, 2012
ALLIANCEBERNSTEIN 1.61M $32.97M Dec. 31, 2012
Ameriprise Financial 1.60M $50.58M Dec. 31, 2014
DIMENSIONAL FUND ADVISORS 1.49M $47.27M Dec. 31, 2014
Apex Capital 1.49M $29.61M June 30, 2013
Ranger Investment Management 1.47M $30.22M Dec. 31, 2012
CITADEL ADVISORS 1.42M $29.19M Sept. 30, 2013
ING Investment Management Co Address: 10 State House Square 1.41M $28.42M Dec. 31, 2011
Name Highfields Capital Management 1.40M $44.35M Dec. 31, 2014
Luther King Capital Management Corporation 1.35M $27.66M Dec. 31, 2012
Jennison Associates 1.33M $42.10M Dec. 31, 2014
RS INVESTMENT MANAGEMENT 1.33M $35.10M March 31, 2014

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 1.57M $34.19M
FRIESS ASSOCIATES March 31, 2011 2.19M $55.70M